
Newlink Genetics (NLNK) Earnings Dates & Reports
Newlink Genetics (NLNK) Most Recent Earnings
Report DateFeb 28, 2020
Period EndingQ4 2019
Est. EPS-$0.28
Actual EPS-$0.22
EarningsBeat
Newlink Genetics (NLNK) Earnings
View the latest Newlink Genetics (NLNK) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Newlink Genetics (NLNK)
Order type
Buy in
Order amount
Est. shares
0 shares
Newlink Genetics (NLNK) Earnings per Share (EPS) History
Signup for full accessBrowse free
Newlink Genetics (NLNK) Latest Earnings
The value each NLNK share was expected to gain vs. the value each share gained.
Newlink Genetics (NLNK) reported its most recent earnings on Feb 28, 2020 for Q4 2019, posting earnings per share (EPS) of -$0.22. This exceeded analysts' expectations of -$0.28 by 21.43%, marking a Beat.
For comparison, Newlink Genetics reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 02/28/2020, with analysts projecting an EPS of $0.
Newlink Genetics (NLNK) Earnings History
Newlink Genetics (NLNK) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Newlink Genetics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|
Newlink Genetics (NLNK) Earnings FAQs
Newlink Genetics (NLNK) last reported earnings on Feb 28, 2020 for Q4 2019, posting an EPS of -$0.22, which Beat the estimate of -$0.28 by 21.43%.
For Q4 2019, Newlink Genetics (NLNK) reported an EPS of -$0.22, exceeding analysts' estimate of -$0.28 by 21.43%.
For Q4 2019, Newlink Genetics (NLNK) Beat expectations with an actual EPS of -$0.22 vs. an estimated EPS of -$0.28.
Following the last earnings report on Feb 28, 2020, Newlink Genetics (NLNK)'s stock price moved — from — to —.
The next Newlink Genetics (NLNK) earnings call is scheduled for Feb. 28, 2020, where executives will discuss financial results and outlook.